Skip to content
Screener

Income Tax at other companies

Pfizer logo
PfizerPFE
-$407M-389%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$3.14M+107%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$347K-99.5%
Sutro Biopharma logo
Sutro BiopharmaSTRO
-$15K-314%
MaxCyte logo
MaxCyteMXCT
$0

Segments

By segment

See full
Single Reportable$1.6K0.0%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$242.07M-31.6%
Enterprise value$151.43M-54.3%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 5:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060382

The Company did not record an income tax provision for the three months ended March 31, 2026 and 2025, primarily due to operating losses and the establishment of a full valuation allowance against its deferred tax assets.

Item 1. Financial Statements.

FAQ

What is Capricor Therapeutics's income tax?
Capricor Therapeutics (CAPR) reported income tax of $0 in Q1 2026.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Ask your AI about Capricor Therapeutics's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude